<DOC>
	<DOCNO>NCT02977702</DOCNO>
	<brief_summary>The primary objective study validate Total Psoas Area ( TPA ) measurement independent prognostic factor overall survival patient pancreatic adenocarcinoma . Secondary objective describe evolution TPA follow-up .</brief_summary>
	<brief_title>Sarcopenia Independent Prognostic Factor Overall Survival Patients With Pancreatic Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Sarcopenia</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>All patient consecutive enrol January 2009 December 2015 underwent least one chemotherapy pancreatic adenocarcinoma , whatever stage A patient record capture outside time frame January 2009 December 2015</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>